NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Cell Bauhaus

Cell Bauhaus

Private
MelbourneHealthcare & Life Scienceshttps://cellbauhaus.com/

Last Round

Grant

Jan 28, 2025

Total Funding Raised

$5.2M

Company Overview

Cell Bauhaus is a software and biotechnology company that develops digital twins of biological cells to simulate and predict the effects of genetic changes on cellular behavior.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine, Vertical SaaS

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting, Government Contracts

AI Layer

Application

Keywords

digital twinsynthetic biologyvirtual cellcomputational biologyin silicobiomanufacturingmetabolic engineeringcell simulationbioengineering softwaregenetic designbio-designSaaSlab automationprecision medicinedrug discovery

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Cell Bauhaus Comparables

Compare Cell Bauhaus with similar companies based on industry and business-model similarity.

Cell Bauhaus comparables — related companies by embedding similarity
CompanySimilarityMarket Cap

View Full Comparables Set

Access detailed peer comparisons, similarity scores, and market data.

Cell Bauhaus Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantJan 28, 2025
SeedOct 8, 2024

Key People

Founding team and executive leadership

Michael Stumpf

Co-Founder And Chief Scientific Officer

Founding Team

Megan Coomer

Co-founder Chief Executive Officer

Founding Team

Cell Bauhaus Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 3, 2025

    Secured $1.9M in grant funding.

  • Oct 8, 2024

    $2.2M round from Tin Alley Ventures and University of Melbourne.

Cell Bauhaus Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Cell Bauhaus Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Cell Bauhaus's valuation, stock price, and market status.

Firmographic Details

HeadquartersMelbourne
Employee Range11
Year Founded2023
Last FundingJan 28, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.